Innovent Biologics and Takeda have formed a global $11.4 billion strategic partnership to accelerate late-stage investigational immuno-oncology and ADC therapies, significantly impacting Asian hospital oncology and pharmacology operations.

Innovent Biologics and Takeda enter a $11.4 billion partnership to co-develop and commercialize advanced immuno-oncology and antibody-drug conjugate therapies worldwide.

Microsoft Corp. has announced new AI enhancements for its clinical assistant, Dragon Copilot, designed to improve patient care, reduce administrative burden, and strengthen operational efficiency in healthcare.

Vivian Health, the largest online marketplace for healthcare talent with over 2.5 million registered users, today announced the launch of its AI Assistant for recruiting. The debut marks Vivian’s evolution into an AI-powered marketplace

Lapsi Health, a rapidly growing health tech innovator with roots in Europe and the U.S., today announced the launch of Keikku 2.0,(pronounced "KAY-koo") a breakthrough medical tool for clinicians. Keikku 2.0 is the first FDA-cleared

Harrison.ai, a global leader in clinical artificial intelligence, today announced it now holds three FDA Breakthrough Device Designations for CT imaging solutions, further solidifying its position at the forefront of next-generation AI for driving efficient, quality patient care.

Smith+Nephew, the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural Terminology (CPT)

Bunkerhill Health has received U.S. Food and Drug Administration (FDA) clearance for Bunkerhill MAC, the first artificial intelligence algorithm designed to detect and quantify mitral annular calcification (MAC) using routine, non-gated chest CT scans.

Cagent Vascular, a leader in endovascular technologies, has announced the commercial launch of the Serranator® PTA Serration Balloon Catheter in 7.0 mm and 8.0 mm diameters. The new sizes extend the benefits of serration technology

Tosoh Bioscience, Inc., a market leader in clinical diagnostics is proud to announce that it has received US FDA 510(k) clearance for its next-generation system for HbA1c testing - the Tosoh Automated Glycohemoglobin Analyzer